![cdc pauses johnson and johnson vaccine cdc pauses johnson and johnson vaccine](https://s3.amazonaws.com/ocn-media/c3e412da-07ed-4139-bd1a-e91bed6d6b18.jpg)
![cdc pauses johnson and johnson vaccine cdc pauses johnson and johnson vaccine](https://dynaimage.cdn.cnn.com/cnn/digital-images/org/12184579-6c70-4228-9117-762e124ba390.jpg)
“The issue of informed consent is complex, and I am concerned that many people maybe don’t have all the information that they would need to give informed consent," said Beth Bell, a clinical professor at the University of Washington's School of Public Health. For those reasons, the panel recommended that the J&J shot still be offered. However, it also acknowledges that the J&J shot still has value when no other vaccine is available, as well as for individuals allergic to the mRNA vaccines. The updated recommendation from the 15-member panel reflects efforts to communicate that the benefits of Pfizer's and Moderna's messenger RNA vaccines outweigh the risks much more than J&J's. “It seems to me today that you presented information to suggest it’s really challenging for us as a clinicians to mitigate the risk of severe complications, potentially," advisory committee Chair Grace Lee said after the new data was presented. nine have died after experiencing clots post-vaccination. More than 17 million people have gotten the J&J vaccine in the U.S. Regulators added warnings to fact sheets distributed to health providers and vaccine recipients, but data shows the proportion of fatal cases didn't fall after the pause. The complication is most prevalent in women ages 30 to 49, but newly released data shows the overall rate of cases is higher than was previously known.įederal officials stopped J&J Covid immunizations in April for 10 days over the potential link to the clots after six cases were identified. The Food and Drug Administration updated its fact sheets earlier this week for the single-dose J&J vaccine to show that about 15 percent of the blood clots some people developed after receiving the shot proved fatal.
CDC PAUSES JOHNSON AND JOHNSON VACCINE UPDATE
Her decision came hours after the agency’s vaccine advisory committee voted unanimously to update the recommendation for the J&J vaccine. Centers for Disease Control and Prevention Director Rochelle Walensky endorsed her advisers’ recommendation Thursday that adults get the Pfizer or Moderna Covid-19 vaccines instead of Johnson & Johnson's shot amid more reports of rare but severe blood clots in some J&J recipients.